Obese mice that exercised while pregnant gave birth to pups that grew up free of the metabolic issues present in the adult young of sedentary obese mothers—possibly by staving off epigenetic changes to a key metabolic gene.

Researchers propose a mechanism by which a protein produced in the placenta may trigger blood vessel growth and enlarge fat cells.

Researchers have collected hundreds of COVID-19–related diabetes case reports since August of last year, in hopes of teasing apart the complex links between the two diseases.

The University of Texas Southwestern scientist studied the roles of glucagon and insulin in regulating blood glucose, leading to several successful treatments.

Lactation boosts the quantity and quality of insulin-producing beta cells in the pancreas, likely reducing a woman’s risk of developing type 2 diabetes.

Breastfeeding reduces type 2 diabetes risk by boosting beta cells.

Insulin-producing cells grown in the lab could offer a functional cure for the disease.

When implanted into mice, the “pseudo-islets” helped treat the animals’ diabetes symptoms.

Results from an observational study find that the introduction of a routine vaccine in Australia coincided with a fall in the incidence of the autoimmune condition.

The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.

Scientists engineered human cells to produce a molecule that stimulates insulin secretion in the presence of caffeine.

One patient with diabetes was able to reduce his medication use while receiving targeted electrical pulses.

A study of more than 450,000 people finds a certain genetic variant associated with eating more carbs is linked to a thicker waist and higher blood pressure, but less fat.  

The new classification system could help improve personalized medicine approaches to the disease.

Pancreatic cells engineered to produce insulin did not immediately provoke an immune response.

A small clinical trial demonstrates that peptide immunotherapy can halt the progression of early-stage type 1 diabetes.

A small patch of engineered cells makes an enzyme that stimulates insulin release.

Scientists have constructed three-dimensional maps depicting the size and location of insulin-producing islet cells in the mouse pancreas.

Researchers produce functional organs composed of both mouse and rat cells.